Here you can find a selection of publications our employees have written in recent years.

 

Chris Oschatz, Coen Maas, Bernd Lecher, Thomas Jansen, Jenny Bjoerkqvist, Thomas Tradler, Reinhard Sedlmeier, Peter Burfeind, Sven Cichon, Sven Hammerschmidt, Werner Mueller-Esterl, Walter A. Wuillemin, Gunnar Nilsson, Thomas Renné

Mast Cells Increase Vascular Permeability by Heparin-Initiated Bradykinin Formation In Vivo

Immunity 2011, doi:10.1016/j.immuni.2011.02.008

 

Wiese E, Maurer S, Steige G, Saaler-Reinhardt S, Lecher B, Ott S, Reifenberg K.

Decontamination of a barrier facility using microisolator cages and provisional partitioning.

Lab Anim 2007 36(7): 31-35

 

Bockamp E, Christel C, Hameyer D, Khobta A, Maringer M, Reis M, Heck R, Cabezas-Wallscheid N, Epe B, Oesch-Bartlomowicz B, Kaina B, Schmitt S, Eshkind L.

Generation and characterization of tTS-H4: a novel transcriptional repressor that is compatible with the reverse tetracycline-controlled TET-ON system.

J Gene Med 2007 9(4): 308-318

 

Bockamp E, Antunes C, Maringer M, Heck R, Presser K, Beilke S, Ohngemach S, Alt R, Cross M, Sprengel R, Hartwig U, Kaina B, Schmitt S, Eshkind L.

Tetracycline-controlled transgenic targeting from the SCL locus directs conditional expression to erythrocytes, megakaryocytes, granulocytes, and c-kit-expressing lineage-negative hematopoietic cells.

Blood 2006 108(5): 1533 - 1541

 

Reifenberg K, Hildt E, Lecher B, Wiese E, Nusser P, Ott S, Yamamura K, Rutter G, Löhler J.

IFNgamma expression inhibits LHBs storage disease and ground glass hepatocyte appearance, but exacerbates inflammation and apoptosis in HBV surface protein-accumulating transgenic livers.

Liver Int 2006 26(8): 986-993

 

Barnewitz K, Maringer M, Mitteregger G, Giese A, Bertsch U, Kretzschmar HA.

Unaltered prion protein cleavage in plasminogen-deficient mice.

Neuroreport 2006 17(5): 527-530

 

Mühlhausen U, Schirrmacher R, Piel M, Lecher B, Briegert M, Piee-Staffa A, Kaina B, Rösch F.

Synthesis of 131I-labeled glucose-conjugated inhibitors of O6-methylguanine-DNA methyltransferase (MGMT) and comparison with nonconjugated inhibitors as potential tools for in vivo MGMT imaging.

J Med Chem 2006 49(1): 263 - 272

 

Trost TM, Lausch EU, Fees SA, Schmitt S, Enklaar T, Reutzel D, Brixel LR, Schmidtke P, Maringer M, Schiffer IB, Heimerdinger CK, Hengstler JG, Fritz G, Bockamp EO, Prawitt D, Zabel BU, Spangenberg C.

Premature senescence is a primary fail-safe mechanism of ERBB2-driven tumorigenesis in breast carcinoma cells.

Cancer Res. 2005 65(3): 840 – 849

 

Bockamp E, Maringer M, Spangenberg C, Fees S, Fraser S, Eshkind L, Oesch F, Zabel B.

Of mice and models: improved animal models for biomedical research.

Physiol Genomics 2002 11(3): 115 - 132

 

Thews O, Hummel M, Kelleher DK, Lecher B, Vaupel P.

Nifedipine improves blood flow and oxygen supply, but not steady-state oxygenation of tumours in perfusion pressurecontrolled isolated limb perfusion.

British J Cancer 2002 87: 1462 - 1469

 

Galli UM, Sauter M, Lecher B, Maurer S, Herbst H, Roemer K, Mueller-Lantzsch N.

Human endogenous retrovirus rec interferes with germ cell development in mice and may cause carcinoma in situ, the predecessor lesion of germ cell tumors.

Oncogen 2005 24(19): 3223-3228